ICCM · IceCure Medical Ltd. · Webcasts, Transcripts & Audio
Market Cap
$8.02M
Shares
4.64M
Volume · Oct 5
159.27K
Avg daily vol (3M)
152.31K
IceCure Medical Ltd. Webcasts
Earnings calls, investor updates, investor days and conferences for IceCure Medical Ltd. (ICCM), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Annual General Meeting
Investor event
2026-11-02
IceCure Medical Ltd. (ICCM) November 2026 Annual General Meeting
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-12
IceCure Medical Ltd. (ICCM) Q2 2026 Earnings Call Transcript
Confident tone
Revenue growth and commercial adoption
CHOICE post-market study
Reimbursement / CPT-1 code
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
IceCure Medical Ltd. (ICCM) Q1 2026 Earnings Call Transcript
Confident tone
U.S. commercial momentum post-FDA
International expansion and other organs
Revenue growth and Q1 results
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-17
IceCure Medical Ltd. (ICCM) Q4 2025 Earnings Call Transcript
Confident tone
FDA marketing authorization for ProSense
Reimbursement and CPT codes
ASBRS guideline recommending cryoablation
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
IceCure Medical Ltd. (ICCM) Q3 2025 Earnings Call Transcript
Confident tone
FDA marketing authorization for ProSense
International expansion and partnerships
Revenue and financial performance
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
IceCure Medical Ltd. (ICCM) Q2 2025 Earnings Call Transcript
Confident tone
FDA Regulatory Progress for ProSense
European Adoption and International Conferences
Japan Partnership with Terumo
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
IceCure Medical Ltd. (ICCM) Q1 2025 Earnings Call Transcript
Confident tone
FDA marketing authorization and post-market study
North America and Europe sales growth
Early-stage breast cancer indication
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
IceCure Medical Ltd. (ICCM) Q2 2024 Earnings Call Transcript
Confident tone
FDA advisory panel for breast cancer
ProSense demand and sales growth
Japan / Terumo partnership
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
IceCure Medical Ltd. (ICCM) Q1 2024 Earnings Call Transcript
Confident tone
ICE3 study and FDA submission for breast cancer
Next-generation XSense system
Global commercial expansion and indications
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
IceCure Medical Ltd. (ICCM) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
IceCure Medical Ltd. (ICCM) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
IceCure Medical Ltd. (ICCM) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
IceCure Medical Ltd. (ICCM) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
IceCure Medical Ltd. (ICCM) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
IceCure Medical Ltd. (ICCM) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
IceCure Medical Ltd. (ICCM) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
IceCure Medical Ltd. (ICCM) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–17 of 17 webcasts